Bravado and complacency highlight the deep chinks in the country’s drug approval and safety processes that are still not good enough to stand global scrutiny.
We rarely make our stories free to read. This one is, so make the most of it.
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
No payment details required
Limited time offer $125 $99 for 1 year
Temasek is largely considered a sovereign wealth fund because it is set up by the Singapore government and invests in other companies. However, a few factors set it apart from other state investors.
Bluesky vs X, the UAE deluge, Adar Poonawalla’s investment in Karan Johar’s Dharma Productions and more.
Indian youngsters are experimenting with newer D2C brands like never before. Bewakoof’s early success and its 2022 acquisition by retail giant Aditya Birla Fashion should have given it the edge, but the company has been left behind.